Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists have transformed weight loss treatment by activating hormones that control hunger and blood sugar. These medications are available in several distinct forms—each with unique absorption patterns, dosing schedules, and clinical profiles. PlexusDx provides access to the full spectrum of GLP-1 options through licensed 503A compounding pharmacies.
Semaglutide Injection vs Oral Formulations
Semaglutide is a synthetic GLP-1 receptor agonist that activates specific receptors in the brain and pancreas to reduce appetite and improve blood sugar control. The injectable version is administered once weekly under the skin and reaches peak blood levels within 1–3 days. PlexusDx compounded semaglutide injections start at $149 per month with no flat per-compound pricing increases.
Oral semaglutide tablets must be taken on an empty stomach to maximize absorption, typically once daily. This formulation reaches lower peak levels than injections but offers convenience for patients who prefer avoiding needles. PlexusDx oral semaglutide begins at $249 per month and provides the same active compound in tablet form.
Tirzepatide: Dual-Action GLP-1 and GIP Receptor Agonist
Tirzepatide is a newer medication that activates both GLP-1 and GIP receptors, creating a dual mechanism of action that may deliver stronger appetite suppression than single-receptor compounds. Research shows tirzepatide produces greater weight loss in clinical trials compared to semaglutide monotherapy, with some patients losing 20% or more of body weight. PlexusDx offers compounded tirzepatide injections starting at $249 per month.
Like semaglutide, tirzepatide is administered once weekly by subcutaneous injection. The oral tirzepatide option at PlexusDx begins at $279 per month for patients seeking tablet-based treatment. Both formulations maintain steady medication levels and require consistent weekly dosing for optimal results.
GLP-Squared: Combining Semaglutide and Tirzepatide
PlexusDx GLP-Squared is a proprietary dual-compound injection that combines semaglutide and tirzepatide into a single weekly injection. This approach leverages the proven efficacy of both medications while simplifying your treatment routine to one shot per week. GLP-Squared injection starts at $249 per month through PlexusDx licensed 503A pharmacies.
The oral GLP-Squared formulation delivers both compounds in tablet form, beginning at $369 per month. This option suits patients who want maximal medication coverage with tablet convenience. PlexusDx ensures both injectable and oral GLP-Squared compounds are prepared by licensed 503A pharmacies and shipped directly to your home across all 50 states.
Microdose GLP-1 Protocol and Genetic Personalization
The PlexusDx Microdose GLP-1 Protocol is a lower-intensity option designed for patients seeking gentler metabolic support or those new to GLP-1 therapy. This protocol includes subcutaneous injections at reduced dosing levels and starts at $129 per month flat—the most affordable entry point for GLP-1 treatment at PlexusDx.
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes 14 metabolic pathways and 150+ genetic insights to identify your individual response patterns. Key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 help predict which GLP-1 formulation and dose level may work best for your genetics. This personalized approach ensures your medication choice aligns with your unique peptide-pathway biology.
Choosing Between Injectable and Oral GLP-1 Medications
Injectable medications achieve higher peak blood levels and may produce faster appetite suppression compared to oral formulations. Weekly injection schedules reduce daily medication burdens and improve adherence for many patients. PlexusDx compounded injections (semaglutide, tirzepatide, and GLP-Squared) provide maximum flexibility within a simple once-weekly routine.
Oral medications offer needle-free convenience and may suit patients with injection anxiety or those who prefer daily pill-taking. Absorption depends on proper fasting periods and gastric pH, making timing and consistency important. PlexusDx offers oral options at every medication tier, ensuring you can select the formulation that fits your lifestyle and preferences without compromise.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between GLP-1 and GIP receptor agonists?
GLP-1 receptor agonists activate hunger-suppression pathways in the brain and pancreas. GIP receptor agonists work on a separate pathway that enhances insulin secretion and may amplify weight loss. Tirzepatide activates both receptors simultaneously, while semaglutide activates only GLP-1 receptors.
How long does semaglutide take to work compared to tirzepatide?
Both medications reach steady-state levels after 4–5 weeks of weekly dosing. Clinical trials show tirzepatide typically produces greater cumulative weight loss than semaglutide, with some patients seeing 20% body weight reduction in 68 weeks.
Can I switch between injectable and oral forms at PlexusDx?
Yes, you can change between formulations based on your needs and preference. PlexusDx supports transitions between semaglutide injection, oral semaglutide, tirzepatide injection, oral tirzepatide, and GLP-Squared options.
Are compounded GLP-1 medications from PlexusDx safe and effective?
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and pharmaceutical standards. Compounded semaglutide and tirzepatide contain the same active pharmaceutical ingredients as brand-name versions.
How does the Precision Peptide Genetic Test help me choose a GLP-1 medication?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic pathways to reveal your genetic predispositions for GLP-1 response. Patients with certain FTO variants may need higher doses for optimal effect, while GIPR-positive individuals may benefit from tirzepatide's dual-action mechanism.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding GLP-1 Medications: Can Young People Take Ozempic?
Fueling Your Morning: What to Eat for Breakfast While on Ozempic for a Healthier You